JONATHAN ORLOFF — Lobbyist Profile | Poliscope

JONATHAN ORLOFF

Reported covered position: N/A

Filings

Clients

Firms

Years active

2000–2004

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
BIOGEN	5	2000–2004

Firm	Filings	Years
BIOGEN	5	2000–2004

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

American Jobs Creation Act of 2003

Client: BIOGEN · Firm: BIOGEN

Cited source text

Jumpstart our Business Strength Act S.1637, H.R. 2896, H.R. 4520 American Jobs Creation Act R&D Tax Credit Repatriation of Foreign Profits

Pharmaceutical Market Access and Drug Safety Act of 2004

Client: BIOGEN · Firm: BIOGEN

Cited source text

General Healthcare issues Monitor/lobby healthcare reform S.2328, Pharmaceutical Market Access and Drug Safety Act, 2004

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

2004 · year_end · YY

Firm income: —Client expense: $430,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

TAX

Taxation/Internal Revenue Code

Jumpstart our Business Strength Act S.1637, H.R. 2896, H.R. 4520 American Jobs Creation Act R&D Tax Credit Repatriation of Foreign Profits

BUD

Budget/Appropriations

Labor HHS Appropriations FY05 VA/HUD Appropriations FY05

HCR

Health Issues